PRESS RELEASE published on 06/15/2023 at 01:52, 1 year 5 months ago MicroVision Announces Withdrawal of Public Offering of Common Stock
PRESS RELEASE published on 06/13/2023 at 22:55, 1 year 5 months ago MicroVision Announces Proposed Public Offering of Common Stock
PRESS RELEASE published on 05/09/2023 at 22:50, 1 year 6 months ago MicroVision Announces First Quarter 2023 Results
PRESS RELEASE published on 05/03/2023 at 22:02, 1 year 6 months ago Independent Proxy Advisory Firms ISS & Glass Lewis Recommend MicroVision Shareholders Vote FOR Proposals at Upcoming Annual Meeting of Shareholders
PRESS RELEASE published on 05/02/2023 at 15:20, 1 year 6 months ago MicroVision to Announce First Quarter 2023 Results on May 9, 2023
PRESS RELEASE published on 04/15/2023 at 00:30, 1 year 7 months ago MicroVision Retail Investor Day Town Hall Session Available For Replay
PRESS RELEASE published on 04/05/2023 at 15:20, 1 year 7 months ago MicroVision Unveils New MOVIA(TM) Sensor and Wins Order for Legacy Sensor
PRESS RELEASE published on 03/29/2023 at 15:20, 1 year 7 months ago MicroVision Announces Plans for Upcoming Investor Conferences
PRESS RELEASE published on 03/23/2023 at 19:00, 1 year 7 months ago MicroVision Announces Retail Investor Day in Redmond, WA on April 14, 2023
PRESS RELEASE published on 03/22/2023 at 14:20, 1 year 7 months ago MicroVision Unveils New MOSAIK(TM) Validation Suite and Begins Cooperation with Jaguar Land Rover
Published on 11/21/2024 at 13:30, 29 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 23 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
